Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 13, 2017 - Issue 7
Submit an article Journal homepage
1,528
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects

Won Suk ChoiDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea
,
Ji Yun NohDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea
,
Joon Young SongDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea
,
Hee Jin CheongDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea
,
Seong-Heon WieDivision of Infectious Diseases, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
,
Jin Soo LeeDivision of Infectious Diseases, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, Republic of Korea
,
Jacob LeeDivision of Infectious Diseases, Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Republic of Korea
,
Shin-Woo KimDivision of Allergic and Infectious Diseases, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea
,
Hye Won JeongDivision of Infectious Diseases, Department of Internal Medicine, Chungbuk University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea
,
Sook-In JungDivision of Infectious Diseases, Chonnam National University Medical School, Gwangju, Republic of Korea
,
Yeon-Sook KimDivisoin of Infectious Diseases, Chungnam National University School of Medicine, Daejeon, Republic of Korea
,
Heung Jeong WooDivision of Infectious Diseases, Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Republic of Korea
,
Kyung Ho KimLife Science Research Institute, SK Chemicals, Seongnam, Gyeonggi-do, Republic of Korea
,
Hun KimLife Science Research Institute, SK Chemicals, Seongnam, Gyeonggi-do, Republic of Korea
&
Woo Joo KimDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
 show all
Pages 1653-1660 | Received 12 Dec 2016, Accepted 16 Feb 2017, Published online: 17 Apr 2017

References

  • Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8; PMID:22226861; https://doi.org/10.1016/j.vaccine.2011.12.098
  • Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 2010; 28:2149-56; PMID:20003926; https://doi.org/10.1016/j.vaccine.2009.11.068
  • Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother 2012; 8:81-8; https://doi.org/10.4161/hv.8.1.17623
  • Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine 2010; 28 Suppl 4:D45-53; PMID:20713260; https://doi.org/10.1016/j.vaccine.2010.08.028
  • World Health Organization. Recommended composition of influenza virus vaccines for use in the 2012–2013 northern hemisphere influenza season. Weekly Epidemiological Record 2012; 87(10):83-95
  • Doroshenko A, Halperin SA. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines). Expert Rev Vaccines 2009; 8:679-88; PMID:19485748; https://doi.org/10.1586/erv.09.31
  • Abelin A, Colegate T, Gardner S, Hehme N, Palache A. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective. Vaccine 2011; 29:1135-8; PMID:21115061; https://doi.org/10.1016/j.vaccine.2010.11.042
  • Choi WS, Kim WJ, Cheong HJ. [The evaluation of policies on 2009 influenza pandemic in Korea]. J Prev Med Public Health 2010; 43:105-8; PMID:20383042; https://doi.org/10.3961/jpmph.2010.43.2.105
  • Emborg HD, Krause TG, Hviid A, Simonsen J, Molbak K. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009–10. BMJ 2012; 344:d7901; https://doi.org/10.1136/bmj.d7901
  • Song JY, Cheong HJ, Lee J, Woo HJ, Wie SH, Lee JS, Kim SW, Noh JY, Choi WS, Kim H, et al. Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial. Vaccine 2015; 33:5437-44; PMID:26314625; https://doi.org/10.1016/j.vaccine.2015.08.030
  • Graaf H, Faust SN. Fluarix quadrivalent vaccine for influenza. Expert Rev Vaccines 2015; 14:1055-63; PMID:26098443; https://doi.org/10.1586/14760584.2015.1057573
  • Suryadevara M, Domachowske JB. Quadrivalent influenza vaccine in the United States. Hum Vaccin Immunother 2014; 10:596-99; https://doi.org/10.4161/hv.27115
  • Block SL, Yi T, Sheldon E, Dubovsky F, Falloon J. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults. Vaccine 2011; 29:9391-7; PMID:21983154; https://doi.org/10.1016/j.vaccine.2011.09.109
  • Greenberg DP, Robertson CA, Noss MJ, Blatter MM, Biedenbender R, Decker MD. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults. Vaccine 2013; 31:770-6; PMID:23228813; https://doi.org/10.1016/j.vaccine.2012.11.074
  • Bart S, Cannon K, Herrington D, Mills R, Forleo-Neto E, Lindert K, Abdul Mateen A. Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study. Hum Vaccin Immunother 2016; 12:2278-88; https://doi.org/10.1080/21645515.2016.1182270
  • Kieninger D, Sheldon E, Lin WY, Yu CJ, Bayas JM, Gabor JJ, Esen M, Fernandez Roure JL, Narejos Perez S, Alvarez Sanchez C, et al. Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged >/=18 years. BMC Infect Dis 2013; 13:343; PMID:23883186; https://doi.org/10.1186/1471-2334-13-343
  • Levandowski RA, Gross PA, Weksler M, Staton E, Williams MS, Bonelli J. Cross-reactive antibodies induced by a monovalent influenza B virus vaccine. J Clin Microbiol 1991; 29:1530-2; PMID:1885750
  • Note for Guidance on Harmonisation of Requirements for Influenza Vaccines (CPMP/BWP/214/96). London, UK: Committee for Proprietary Medicinal Products (CPMP), 1997
  • Guidance for Industry: Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2007
  • Guidance for industry: clinicaldata needed to support the licensure of trivalent inactivated influenza vaccines. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2006

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.